DSpace Repository

AM3 Modulates Dendritic Cell Pathogen Recognition Capabilities by Targeting DC-SIGN

Show simple item record

dc.creator Serrano-Gómez, Diego
dc.creator Martínez-Nuñez, Rocío T.
dc.creator Sierra-Filardi, Elena
dc.creator Izquierdo, Nuria
dc.creator Colmenares, María
dc.creator Pla, Jesús
dc.creator Rivas, Luis
dc.creator Martinez-Picado, Javier
dc.creator Jiménez-Barbero, Jesús
dc.creator Alonso-Lebrero, José Luis
dc.creator González, Salvador
dc.creator Corbí, Angel L.
dc.date 2008-02-06T13:08:49Z
dc.date 2008-02-06T13:08:49Z
dc.date 2007-04-23
dc.date.accessioned 2017-01-31T00:59:58Z
dc.date.available 2017-01-31T00:59:58Z
dc.identifier PMCID: 1913256
dc.identifier Antimicrobial Agents and Chemotherapy 2007 July; 51(7): 2313–2323
dc.identifier 0066-4804
dc.identifier http://hdl.handle.net/10261/2878
dc.identifier 10.1128/AAC.01289-06
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10261/2878
dc.description AM3 (Inmunoferon) is an orally effective immunomodulator that influences the regulatory and effector functions of the immune system whose molecular mechanisms of action are mostly unknown. We hypothesized that the polysaccharide moiety of AM3 (IF-S) might affect immune responses by modulating the lectin-dependent pathogen recognition abilities of human dendritic cells. IF-S inhibited binding of viral, fungal, and parasite pathogens by human monocyte-derived dendritic cells in a dose-dependent manner. IF-S specifically impaired the pathogen recognition capabilities of DC-SIGN, as it reduced the attachment of Candida, Aspergillus, and Leishmania to DC-SIGN transfectants. IF-S also inhibited the interaction of DC-SIGN with both its cellular counterreceptor (intercellular adhesion molecule 3) and the human immunodeficiency virus (HIV) type 1 gp120 protein and blocked the DC-SIGN-dependent capture of HIV virions and the HIV trans-infection capability of DC-SIGN transfectants. IF-S promoted DC-SIGN internalization in DCs without affecting mannose receptor expression, and 1D saturation transfer difference nuclear magnetic resonance demonstrated that IF-S directly interacts with DC-SIGN on the cell surface. Therefore, the polysaccharide moiety of AM3 directly influences pathogen recognition by dendritic cells by interacting with DC-SIGN. Our results indicate that DC-SIGN is the target for an immunomodulator and imply that the adjuvant and immunomodulatory actions of AM3 are mediated, at least in part, by alteration of the DC-SIGN functional activities.
dc.description This work was supported by the Ministerio de Educación y Ciencia (grants SAF2005-0021, AGL2004-02148-ALI, and GEN2003-20649-C06-01/NAC), the Fundación para la Investigación y Prevención del SIDA en España (grant FIPSE 36422/03), the Fundación de Investigación Médica Mutua Madrileña (grant 20060789), and the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Spanish Network for the Research in Infectious Diseases, grant REIPI RD06/0008), to A.L.C. and grant SAF2004-06991 to J.M.-P. D.S.-G. was supported by a predoctoral grant (grant AP2002-2151) from the Ministerio de Educación y Ciencia (Spain). R.T.M.-N. was funded by Beca de Introducción a la Investigación fellowship from the Consejo Superior de Investigaciones Científicas (CSIC).
dc.description Peer reviewed
dc.format 630785 bytes
dc.format application/pdf
dc.language eng
dc.publisher American Society for Microbiology
dc.rights closedAccess
dc.title AM3 Modulates Dendritic Cell Pathogen Recognition Capabilities by Targeting DC-SIGN
dc.type Artículo


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account